Importantly, CD9 expression also strongly correlates with active Rac1 in primary B-ALL patient blasts and CD9 was recently proposed as a marker for poor prognosis in ALL [86], highlighting an indirect role for Rac1 in the prognosis of ALL. The gene discussed is RAC1; the disease is acute lymphoblastic leukemia.